Literature DB >> 14576528

Treatment of ligneous conjunctivitis with topical plasmin and topical plasminogen.

David G Heidemann1, George A Williams, Michael Hartzer, Alexandra Ohanian, Matthew E Citron.   

Abstract

PURPOSE: To describe treatment of a child with recalcitrant ligneous conjunctivitis secondary to a systemic plasminogen deficiency.
DESIGN: Interventional case report.
METHODS: A seven-year-old boy developed severe unilateral membranous conjunctivitis recalcitrant to surgical debridement and treatment with topical prednisone, topical cyclosporine, and oral prednisone. Systemic evaluation revealed a severe plasminogen deficiency.
RESULTS: Treatment with surgical debridement and topical plasmin was ineffective and resulted in prompt recurrence of dense conjunctival membranes. Treatment with topical plasminogen resulted in dramatic improvement and complete resolution of the membranes.
CONCLUSIONS: Ligneous conjunctivitis is secondary to a systemic plasminogen deficiency. Treatment with topical plasminogen resulted in prompt resolution of the membranes. Treatment with topical plasmin was ineffective.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14576528     DOI: 10.1097/00003226-200311000-00009

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  3 in total

Review 1.  Plasminogen deficiency.

Authors:  Tiraje Celkan
Journal:  J Thromb Thrombolysis       Date:  2017-01       Impact factor: 2.300

2.  Recurrent ligneous conjunctivitis after cataract surgery in a 67-year-old male patient: a case report.

Authors:  Amine Maamri; Elena Zemova; Kayed Moslemani; Fidelis Flockerzi; Berthold Seitz
Journal:  BMC Ophthalmol       Date:  2022-03-05       Impact factor: 2.209

3.  Treatment of ligneous conjunctivitis with amniotic membrane transplantation and topical cyclosporine.

Authors:  Ozlem Yalcin Tok; Fatma Akbas Kocaoglu; Levent Tok; Ayse Burcu; Firdevs Ornek
Journal:  Indian J Ophthalmol       Date:  2012 Nov-Dec       Impact factor: 1.848

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.